Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 2, 2007, Pages 443-449

  Rauchenzauner, Markus ^a   Schmid, Andrea ^a   Heinz Erian, Peter ^a   Kapelari, Klaus ^a   Falkensammer, Gerda ^b   Griesmacher, Andrea ^b   Finkenstedt, Gerd ^a   Högler, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; OSTEOCALCIN;

ADOLESCENT; ADULT; AGE DETERMINATION; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; BONE TURNOVER; CHILD; COLLAGEN SYNTHESIS; DEVELOPMENTAL STAGE; FEMALE; HUMAN; INFANT; MALE; NORMAL HUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBERTY; REFERENCE VALUE; SCORING SYSTEM; SEX RATIO;

EID: 33847006920     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1706     Document Type: Article

References (62)

1. Miller PD 2005 Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction. Curr Osteoporos Rep 3:103-110
2. Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Chaki O, Ichimura S, Nakatsuka K, Miura M 2005 Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004). J Bone Miner Metab 23:97-104
3. Bonnick SL, Shulman L 2006 Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? Am J Med 119:S25-31
4. Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD 2002 Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87:1586-1592
5. Miller PD, Shergy WJ, Body JJ, Chen P, Rohe ME, Krege JH 2005 Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate. J Rheumatol 32:1556-1562
6. Hannon RA, Eastell R 2006 Bone markers and current laboratory assays. Cancer Treat Rev 32(Suppl 1):7-14
7. Crofton PM, Kelnar CJ 1998 Bone and collagen markers in paediatric practice. Int J Clin Pract 52:557-565
8. de Ridder CM, Delemarre-van de Waal HA 1998 Clinical utility of markers of bone turnover in children and adolescents. Curr Opin Pediatr 10:441-448
9. Schonau E, Rauch F 1997 Markers of bone and collagen metabolism-problems and perspectives in paediatrics. Horm Res 48(Suppl 5):50-59
10. Szulc P, Seeman E, Delmas PD 2000 Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 11:281-294
11. van Coeverden SC, Netelenbos JC, de Ridder CM, Roos JC, Popp-Snijders C, Delemarre-van de Waal HA 2002 Bone metabolism markers and bone mass in healthy pubertal boys and girls. Clin Endocrinol (Oxf) 57:107-116
12. Mora S, Prinster C, Proverbio MC, Bellini A, de Poli SC, Weber G, Abbiati G, Chiumello G 1998 Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty. Calcif Tissue Int 63:369-374
13. Zanze M, Souberbielle JC, Kindermans C, Rossignol C, Garabedian M 1997 Procollagen propeptide and pyridinium cross-links as markers of type I collagen turnover: sex- and age-related changes in healthy children. J Clin Endocrinol Metab 82:2971-2977
14. Fujimoto S, Kubo T, Tanaka H, Miura M, Seino Y 1995 Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency. J Clin Endocrinol Metab 80:1922-1928
15. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, DiNero G 1994 Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children. Pediatr Res 35:409-415
16. Rauch F, Schonau E, Woitge H, Remer T, Seibel M 1994 Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children. Exp Clin Endocrinol 102:94-97
17. Forbes GB, Bruining GJ 1976 Urinary creatinine excretion and lean body mass. Am J Clin Nutr 29:1359-1366
18. Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H 2003 Markers of bone resorption-measurement in serum, plasma or urine? Clin Lab 49:203-207
19. Calvo MS, Eyre DR, Gundberg CM 1996 Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17:333-368
20. Hogler W, Schmid A, Raber G, Solder E, Eibl G, Heinz-Erian P, Kapelari K 2003 Perinatal bone turnover in term human neonates and the influence of maternal smoking. Pediatr Res 53:817-822
21. Rauch F, Schnabel D, Seibel MJ, Remer T, Stabrey A, Michalk D, Schonau E 1995 Urinary excretion of galactosyl-hydroxylysine is a marker of growth in children. J Clin Endocrinol Metab 80:1295-1300
22. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Gneiß H, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, Mueller G, Mueller J, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen H, Zabransky S, zellner K, Ziegler A, Hebebrand J 2001 Perzentilen für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde 149:807-818
23. Tanner J 1978 Physical growth and development. In: Forfar, JO, Arnell, CC, eds. Textbook of pediatrics. 2nd ed. Edinburgh: Churchill Livingstone; 249-303
24. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L 1993 Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 39:635-640
25. Altman DG 1993 Construction of age-related reference centiles using absolute residuals. Stat Med 12:917-924
26. Crofton PM, Stirling HF, Schonau E, Kelnar CJ 1996 Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children. Clin Endocrinol (Oxf) 44:385-394
27. Rauch F, Georg M, Stabrey A, Neu C, Blum WF, Remer T, Manz F, Schoenau E 2002 Collagen markers deoxypyridinoline and hydroxylysine glycosides: pediatric reference data and use for growth prediction in growth hormone-deficient children. Clin Chem 48:315-322
28. Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG 2001 The IGF-I generation test revisited: a marker of GH sensitivity. J Clin Endocrinol Metab 86:5176-5183
29. Schwarze CP, Wollmann HA, Binder G, Ranke MB 1999 Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children. Acta Paediatr (Suppl 88):200-208
30. Schonau E 1997 Growth prediction with biochemical markers and its consequences. Eur J Endocrinol 137:603-604
31. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R 1998 Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339:947-952
32. Astrom E, Soderhall S 2002 Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 86:356-364
33. Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH 2003 Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab 88:986-992
34. Allgrove J 2002 Use of bisphosphonates in children and adolescents. J Pediatr Endocrinol Metab 15 (Suppl 3):921-928
35. Batch JA, Couper JJ, Rodda C, Cowell CT, Zacharin M 2003 Use of bisphosphonate therapy for osteoporosis in childhood and adolescence. J Paediatr Child Health 39:88-92
36. Srivastava T, Alon US 2003 The role of bisphosphonates in diseases of childhood. Eur J Pediatr 162:735-751
37. Baroncelli GI, De Luca F, Magazzu G, Arrigo T, Sferlazzas C, Catena C, Bertelloni S, Saggese G 1997 Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr Res 41:397-403
38. Cowan FJ, Warner JT, Dunstan FD, Evans WD, Gregory JW, Jenkins HR 1997 Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 76:325-329
39. Munns CF, Cowell CT 2005 Prevention and treatment of osteoporosis in chronically ill children. J Musculoskelet Neuronal Interact 5:262-272
40. Pereira RM, Falco V, Corrente JE, Chahade WH, Yoshinari NH 1999 Abnormalities in the biochemical markers of bone turnover in children with juvenile chronic arthritis. Clin Exp Rheumatol 17:251-255
41. van Staa TP, Cooper C, Leufkens HG, Bishop N 2003 Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 18:913-918
42. Ward LM 2005 Osteoporosis due to glucocorticoid use in children with chronic illness. Horm Res 64:209-221
43. Hogler W, Wehl G, van Staa T, Meister B, Klein-Franke A, Kropshofer G 2007 Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the general practice research database. Pediatr Blood Cancer 48:21-27
44. Land C, Rauch F, Glorieux FH 2006 Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta. J Bone Miner Res 21:374-379
45. Rauch F, Munns C, Land C, Glorieux FH 2006 Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation. J Clin Endocrinol Metab 91:1268-1274
46. Rauch F 2005 Bone growth in length and width: the Yin and Yang of bone stability. J Musculoskelet Neuronal Interact 5:194-201
47. Caino S, Kelmansky D, Adamo P, Lejarraga H 2006 Short-term growth in healthy infants, schoolchildren and adolescent girls. Ann Hum Biol 33:213-226
48. Hogler W, Blimkie CJ, Cowell CT, Kemp AF, Briody J, Wiebe P, Farpour-Lambert N, Duncan CS, Woodhead HJ 2003 A comparison of bone geometry and cortical density at the mid-femur between prepuberty and young adulthood using magnetic resonance imaging. Bone 33:771-778
49. Kontulainen SA, Macdonald HM, Khan KM, McKay HA 2005 Examining bone surfaces across puberty: a 20-month pQCT trial. J Bone Miner Res 20: 1202-1207
50. Chen CJ, Chao TY, Janckila AJ, Cheng SN, Ku CH, Chu DM 2005 Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children-a novel marker for bone growth. J Pediatr Endocrinol Metab 18:55-62
51. Crofton PM, Evans N, Taylor MR, Holland CV 2002 Serum CrossLaps: pediatric reference intervals from birth to 19 years of age. Clin Chem 48:671-673
52. Crofton PM, Wade JC, Taylor MR, Holland CV 1997 Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren. Clin Chem 43:1577-1581
53. Kubo T, Tanaka H, Inoue M, Kanzaki S, Seino Y 1995 Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy. Bone 17:397-401
54. Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake T, Yamauchi S, Tanaka H, Seino Y 1997 Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab 82:2056-2061
55. Tsai KS, Jang MH, Hsu SH, Cheng WC, Chang MH 1999 Bone alkaline phosphatase isoenzyme and carboxy-terminal propeptide of type-I procollagen in healthy Chinese girls and boys. Clin Chem 45:136-138
56. Cioffi M, Molinari AM, Gazzerro P, Di Finizio B, Fratta M, Deufemia A, Puca GA 1997 Serum osteocalcin in 1634 healthy children. Clin Chem 43:543-545
57. Johansen JS, Giwercman A, Hartwell D, Nielsen CT, Price PA, Christiansen C, Skakkebaek NE 1988 Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone. J Clin Endocrinol Metab 67:273-278
58. Kikuchi T, Hashimoto N, Kawasaki T, Kataoka S, Takahashi H, Uchiyama M 1998 Plasma levels of carboxy terminal propeptide of type I procollagen and pyridinoline cross-linked telopeptide of type I collagen in healthy school children. Acta Paediatr 87:825-829
59. Tommasi M, Bacciottini L, Benucci A, Brocchi A, Passeri A, Saracini D, D'Agata A, Cappelli G 1996 Serum biochemical markers of bone turnover in healthy infants and children. Int J Biol Markers 11:159-164
60. Mora S, Pitukcheewanont P, Kaufman FR, Nelson JC, Gilsanz V 1999 Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res 14:1664-1671
61. Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R 2002 Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 30:886-890
62. Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C 2002 Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31:57-61